Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03402893 · ClinicalTrials.gov registry record · Phase 4
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
A Phase 4 study of Acne Vulgaris and Post-inflammatory Hyperpigmentation, sponsored by Derm Research, P.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT03402893 is a Phase 4 study of Acne Vulgaris and Post-inflammatory Hyperpigmentation that has completed, run by Derm Research, P. The registered enrollment target is 21 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03402893, a Phase 4 study of Acne Vulgaris and Post-inflammatory Hyperpigmentation, has completed, sponsored by Derm Research, P.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and Weeks 4, 8, and 16. All subjects will receive Onexton at Baseline and be instructed to apply the gel once daily to the face. The investigators will evaluate Investigator Global Assessment of acne (IGA), total lesion count, inflammatory lesion count, non-inflammatory lesion count, Investigator Global Assessment of Post-Inflammatory Hyperpigmentation and distribution of Post-Inflammatory Hyperpigmentation, adverse events and concomitant medications.
Conditions Studied
Interventions
- DRUG ONEXTON Topical Gel
Study Locations (1)
Kentucky
- DermResearch, PLLC - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-07-28 |
| Est. Completion | 2018-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03402893
The ClinicalTrials.gov registry entry for NCT03402893 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (92% lower). The listed sponsor is Derm Research, P, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which ONEXTON Topical Gel is the first listed.
NCT03402893 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT03402893 about?
NCT03402893 is a clinical study titled "The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color". This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and Weeks 4, 8, and 16. All subjects will receive Onexton at Baseline and be instructed to apply the gel once daily to the face. The investigators will evaluate Investigator Global Assessm...
What is the current status of trial NCT03402893?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2017-07-28. Estimated completion is 2018-02-28.
What conditions does trial NCT03402893 study?
This clinical trial studies the following conditions: Acne Vulgaris, Post-inflammatory Hyperpigmentation.
What interventions are being tested in trial NCT03402893?
The interventions under investigation include: ONEXTON Topical Gel (DRUG).
Who is sponsoring clinical trial NCT03402893?
This trial is sponsored by Derm Research, P, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03402893 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
ACTIVE NOT RECRUITING · Phase 4
-
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
COMPLETED · Phase 4
-
AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation
COMPLETED · Phase 4
-
A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)
COMPLETED · Phase 4
-
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
COMPLETED · Phase 4
-
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.